Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07875231
PHASE4

Dexmedetomidine Infusion and Iscemia and Reperfusion Injury

Sponsor: Diskapi Yildirim Beyazit Education and Research Hospital

View on ClinicalTrials.gov

Summary

The effect of deksmedetomidine infusion on ischemia-reperfusion injury related to tourniquet application during total knee replacement will be evaluated by malondialdehyde and total antioksidant status.

Official title: The Effect of Dexmedetomidine Infusion on Turniquet Induced Iscemia and Reperfusion Injury in Total Knee Replacement Surgery

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2015-12

Completion Date

2016-04

Last Updated

2026-10-15

Healthy Volunteers

No

Conditions

Interventions

DRUG

Dexmedetomidine

0.1 mcg/kg/min 10 minutes dexmedetomidine infusion followed by 0.2-0.7 mcg/kg/hour dexmedetomidine infusion

DRUG

saline

0.1 mcg/kg/min 10 minutes saline infusion followed by 0.2-0.7 mcg/kg/hour saline infusion